股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 致：香港交易及結算所有限公司 公司名稱: 新百利融資控股有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08439 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,00 ...

（於開曼群島註冊成立之有限公司） （股份代號：8439） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 SOMERLEY CAPITAL HOLDINGS LIMITED Somerley Capital Holdings Limited 新百利融資控股有限公司 於2025年9月29日舉行之股東週年大會投票表決結果 新百利融資控股有限公司（「本公司」）欣然宣佈，在本公司於2025年9月29日（星期 一）上午十一時正假座香港銅鑼灣禮頓道77號禮頓中心17樓舉行之股東週年大會 （「股東週年大會」）上，載於包括日期為2025年6月27日之股東週年大會通告（「該通 告」）在內之通函（「該通函」）之所有決議案（「決議案」）已獲股東以投票方式正式通 過。除另有界定外，本公告所用詞彙與該通函所界定者具有相同涵義。 於股東週年大會上提呈之決議案的投票表決結果如下： | | 普通決議案 | 投票數目 （概約%） | | | --- | --- | --- | --- ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新百利融資控股有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年9月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08439 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,000 ...

Group 1 - The core point of the news is that Kangji Medical (09997.HK) has appointed New Baili Financing Limited as an independent financial advisor to assess the fairness and reasonableness of the terms related to a proposed plan and special transactions [1][2] - The independent board committee will receive advice from the appointed financial advisor regarding voting matters [1] - Kangji Medical plans to hold a board meeting on August 28 to approve its interim results [2]

康基医疗(09997)发布公告，新百利融资有限公司(一间根据证券及期货条例可从事第1类(证券交易)及第 6类(就机构融资提供意见)受规管活动的持牌法团)已获委任为独立财务顾问，就该建议、该计划及特别 交易的条款是否属公平合理以及投票事宜向独立董事委员会提供意见。独立财务顾问的委任已根据收购 守则第2.1条获独立董事委员会批准。 ...

Group 1 - The core point of the article is that Kangji Medical (09997) has appointed New Baili Financing Limited as an independent financial advisor to provide opinions on the fairness and reasonableness of the terms of a proposed plan and special transactions, as well as voting matters [1] Group 2 - The appointment of the independent financial advisor has been approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code [1]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新百利融資控股有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08439 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 200,000,000 | HKD | | 0.01 | HKD | | 2,000 ...

（於開曼群島註冊成立之有限公司） 股份代號：8439 2024/25 年報 2024/25 ANNUAL REPORT (Incorporated in the Cayman Islands with limited liability) Stock code : 8439 ANNUAL RE P O R 董事會 T 年報 2024/25 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上市的公司帶有較高投資風險。有意投資 的人士應了解投資於該等公司的潛在風險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣之證券可能會較於主板買賣之證券承受較大的市場波動風險，同時無法保 證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就 因本報告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本年報的資料乃遵照聯交所GEM證券上市規則（「GEM上市規則」）而刊載，旨在提供有關新百利融資 ...

Company Performance - Somerley Capital Holdings Limited provided a supplementary announcement regarding its annual performance for the year ending March 31, 2025[2]. - The board confirmed that the information disclosed in the announcement does not affect the previously reported annual performance and consolidated financial statements[2]. Audit and Financial Reporting - The audit committee reviewed the accounting principles and practices adopted by the group, discussing audit, internal control, and financial reporting matters[2]. - The board collectively and individually accepts full responsibility for the accuracy and completeness of the information in the announcement[5]. Compliance and Availability - The announcement is published in accordance with GEM listing rules and aims to provide information about the company[5]. - The announcement will be available on the Hong Kong Stock Exchange website for at least seven days from the publication date[5]. Board of Directors - The executive directors include Sabine Martin Nevil, Zhuang Disheng, Zou Weihong, Liang Nianwu, and Wang Sijun[4]. - Independent non-executive directors include Zheng Yuhua, Yuan Jintian, and Luo Zhuojian[4].

Financial Performance - For the fiscal year ending March 31, 2025, the total revenue was approximately HKD 51.6 million, a decrease of about 23.4% compared to HKD 67.4 million in 2024[4] - The group recorded a pre-tax loss of approximately HKD 13.9 million, significantly increasing from a pre-tax loss of HKD 3.6 million in 2024[4] - The adjusted pre-tax loss for the fiscal year was approximately HKD 10.5 million, compared to a profit of HKD 0.843 million in 2024[7] - The company reported a net loss of approximately HKD 13.8 million for the year, compared to a net loss of HKD 3.6 million in 2024, indicating a significant decline in financial performance[41] - The group experienced a total comprehensive loss of approximately HKD 13.8 million for the year, compared to a comprehensive loss of HKD 3.6 million in 2024[42] - The company reported a pre-tax loss of HKD 13,854,000 for the year ended March 31, 2025, compared to a pre-tax loss of HKD 3,580,000 for the previous year, indicating a significant increase in losses[62] Revenue Breakdown - Revenue from financial advisory services was approximately HKD 33.7 million, accounting for about 65.3% of total revenue, down from 63.8% in 2024[4] - Revenue from compliance advisory services was approximately HKD 17.3 million, representing about 33.5% of total revenue, a decrease attributed to a reduction in IPO activity and the loss of existing compliance contracts[13] - The revenue from financial advisory and independent financial advisory services amounted to approximately HKD 33.7 million, accounting for about 65.3% of total revenue, down from 63.8% in 2024[12] - The company reported a decrease in advisory fees from financial consulting, with revenue from acting as a financial advisor dropping to HKD 14,842,000 in 2025 from HKD 20,340,000 in 2024[60] Cost Management - The group implemented a cost optimization plan starting December 2024, aiming to reduce average employee benefits and operating expenses by approximately HKD 1.0 million per month[9] - The group’s total operating expenses decreased due to the cost optimization plan, which partially offset the revenue decline[9] - Employee benefit costs decreased by approximately 7.5% to about HKD 49.4 million from HKD 53.4 million in 2024, primarily due to a revised compensation structure[20] - Depreciation and other operating expenses decreased by approximately 17.3% to about HKD 15.3 million from HKD 18.5 million in 2024, mainly due to enhanced cost control measures[22] Asset and Liability Management - The net asset value decreased from approximately HKD 78.5 million as of March 31, 2024, to approximately HKD 62.5 million as of March 31, 2025, primarily due to the loss incurred during the year[4] - The group's cash and cash equivalents as of March 31, 2025, were approximately HKD 51.6 million, down from HKD 60.2 million in 2024, reflecting a decrease of 11.4%[28] - The current ratio as of March 31, 2025, was 7.6 times, down from 10.7 times in 2024, indicating a decline in liquidity[28] - Total liabilities increased significantly to HKD 9,997,000 in 2025 from HKD 1,402,000 in 2024, marking a rise of 612.4%[44] - Equity attributable to owners decreased to HKD 62,481,000 in 2025 from HKD 78,443,000 in 2024, a decrease of 20.4%[44] Strategic Initiatives - The company is cautiously evaluating various methods to restart its asset management business in light of current market conditions[10] - The company has entered into a supplemental agreement with CoinstreetPro (Global) Limited to further invest in its subsidiary, indicating ongoing strategic initiatives[18] Dividend and Shareholder Information - The board proposed a final dividend of HKD 0.02 per share, down from HKD 0.025 per share in 2024, subject to shareholder approval[4] - The proposed final dividend for the year ending March 31, 2025, is HKD 0.02 per share, down from HKD 0.025 per share in 2024[68] - The basic and diluted loss per share attributable to the company's owners is HKD (13,809,000) for 2025, compared to HKD (3,543,000) for 2024, with a weighted average number of shares of 146,769,000 for 2025[69] Governance and Compliance - The company has adopted the corporate governance code as a benchmark for its governance practices, ensuring compliance throughout the year[85] - The audit committee held four meetings during the year, focusing on reviewing annual and interim financial statements[89] - The audit committee has reviewed the efficiency of the internal control system and the adequacy of accounting and financial reporting resources[93] - The company plans to continue its relationship with the auditor, KPMG, pending shareholder approval at the upcoming annual general meeting[91] Market Conditions and Risks - The group faced significant challenges in the Hong Kong corporate finance market due to economic uncertainties and geopolitical tensions, impacting investor confidence and transaction completion[6] - The group faced significant risks including reliance on its corporate finance advisory segment, which is subject to economic fluctuations and regulatory changes[37]